10-133528614-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000773.4(CYP2E1):c.311C>T(p.Pro104Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,613,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P104S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP2E1 | NM_000773.4 | c.311C>T | p.Pro104Leu | missense_variant | 2/9 | ENST00000252945.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP2E1 | ENST00000252945.8 | c.311C>T | p.Pro104Leu | missense_variant | 2/9 | 1 | NM_000773.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000180 AC: 45AN: 250110Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135678
GnomAD4 exome AF: 0.000267 AC: 390AN: 1461032Hom.: 0 Cov.: 31 AF XY: 0.000253 AC XY: 184AN XY: 726812
GnomAD4 genome AF: 0.000164 AC: 25AN: 152322Hom.: 0 Cov.: 34 AF XY: 0.000121 AC XY: 9AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.311C>T (p.P104L) alteration is located in exon 2 (coding exon 2) of the CYP2E1 gene. This alteration results from a C to T substitution at nucleotide position 311, causing the proline (P) at amino acid position 104 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at